beat·365(中国)官方网站-最新版

客户简介

Shanghai Kehua Bioengineering Co., Ltd

Founded in 1981, it is the first diagnostic supplies professional company in China to be listed on the small and medium-sized board of the Shenzhen Stock Exchange. It integrates product research and development, production, and sales, and has a complete industrial chain in the field of medical diagnosis. The company's main business covers in vitro diagnostic reagents and medical laboratory instruments. As a research and development driven high-tech enterprise, the company has established two major research and development technology platforms, clinical in vitro diagnostic reagents and fully automated detection and analysis instruments, relying on the Biotechnology Innovation Center and postdoctoral research workstations, gradually promoting the "serialization" and "integration" development goals of reagents and instruments; The company's product line extension strategy has achieved significant results: it has obtained over a hundred product production approvals, 69 reagent and instrument products have passed the EU CE certification, and its main products have a leading domestic market share; While building an excellent domestic marketing network, the company is actively expanding the international market. Kehua brand products have been exported to 38 countries and regions overseas. AIDS diagnostic reagents have been included in the purchase list of the World Health Organization, the United Nations Children's Fund, the President's Fund of the United States and other internationally renowned institutions, and signed a long-term supply contract with the Clinton Foundation of the United States.